Litcius/Paper detail

Computational insights into the known inhibitors of human soluble epoxide hydrolase

Maria Bzówka, Karolina Mitusińska, Katarzyna Hopko, Artur Góra

2021Drug Discovery Today24 citationsDOIOpen Access PDF

Abstract

Human soluble epoxide hydrolase (hsEH) is involved in the hydrolysis of epoxyeicosatrienoic acids (EETs), which have potent anti-inflammatory properties. Given that EET conversion generates nonbioactive molecules, inhibition of this enzyme would be beneficial. Past decades of work on hsEH inhibitors resulted in numerous potential compounds, of which a hundred hsEH-ligand complexes were crystallized and deposited in the Protein Data Bank (PDB). We analyzed all deposited hsEH-ligand complexes to gain insight into the binding of inhibitors and to provide feedback on the future drug design processes. We also reviewed computationally driven strategies that were used to propose novel hsEH inhibitors.

Topics & Concepts

Epoxide hydrolase 2Protein Data Bank (RCSB PDB)Small moleculeEpoxide hydrolaseLigand (biochemistry)ChemistryHydrolaseEnzymeComputational biologyDrug discoveryBiochemistryCombinatorial chemistryStereochemistryBiologyReceptorMicrosomeEicosanoids and Hypertension PharmacologyPharmacogenetics and Drug MetabolismHormonal Regulation and Hypertension